Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Emergency contraceptives

This article was originally published in The Tan Sheet

Executive Summary

Movement among advocacy groups could lead to a citizen petition for OTC sale of ECs, James Trussell, PhD, Princeton University Office of Population Research, confirms at a Nov. 16 briefing sponsored by the Henry J. Kaiser Family Foundation. The National Black Women's Health Project, National Women's Health Network, National Abortion Rights Action League and Population Council have voiced support for lessening Rx restrictions on ECs (1"The Tan Sheet" July 10, p. 3). Preven marketer Gynetics and Women's Capital Corporation, which markets Plan B, have expressed interest in bringing their Rx emergency contraceptives over-the-counter, although neither has filed a switch NDA

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091905

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel